SCHEMBL6628361

SCHEMBL6628361

COc1ccc(N2CCN(CCc3ccc(OC)c(C)c3C)CC2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.56
▸ MAPT P10636 1/20 0.56
▸ HTR7 P34969 1/20 0.51
▸ MEN1 O00255 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ SIGMAR1 Q99720 3/20 0.47
▸ KCNH2 Q12809 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NR1I2 O75469 1/20 0.45
▸ ADRB1 P08588 1/20 0.45
▸ HTR1A P08908 1/20 0.45
▸ ADRA2A P08913 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ DRD2 P14416 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ADRA2C P18825 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ HTR2A P28223 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6625036 0.91 LMNA (0.55) LMNAMAPTHTR7MEN1KMT2A
SCHEMBL5183561 0.90 LMNA (0.52) LMNAMAPTHTR7MEN1KMT2A
SCHEMBL5183909 0.87 LMNA (0.51) LMNAMAPTHTR7MEN1KMT2A
SCHEMBL5183035 0.85 LMNA (0.49) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL5243868 0.83 LMNA (0.45) LMNAMAPTHTR7MEN1KMT2A
SCHEMBL6622755 0.82 LMNA (0.47) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL5241842 0.81 LMNA (0.43) LMNAMAPTMEN1KMT2ADRD2
SCHEMBL5242970 0.81 LMNA (0.43) LMNAMAPTHTR7HTR1ADRD2
SCHEMBL5242204 0.80 LMNA (0.42) LMNAMAPTMEN1KMT2AKCNH2
SCHEMBL5243013 0.80 HTR1A (0.43) LMNAMAPTHTR7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389189-A2 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES NEUROGEN CORPORATION (US) 2004-02-18 — — EP claimed
WO-2002094799-A2 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES NEUROGEN CORPORATION (US) 2002-11-28 — — WO claimed
EP-1389189-A2 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES NEUROGEN CORPORATION (US) 2004-02-18 — — EP disclosed
WO-2002094799-A2 MELANIN CONCENTRATING HORMONE RECEPTOR LIGANDS: SUBSTITUTED 1-BENZYL-4-ARYL PIPERAZINE ANALOGUES NEUROGEN CORPORATION (US) 2002-11-28 — — WO disclosed
Send feedback